False Claims Act (“FCA”) cases brought by the Department of Justice (“DOJ”) returned only $2.2 billion in recovered funds in 2020, down from $3.0 billion in 2019 and $2.9 billion in 2018, making 2020’s FCA recovery amount the lowest since... Read More
Blogs & Articles | Healthcare | Healthcare Law | White Collar Defense and Government Investigation

The last few years have brought on a slew of litigation aimed at combatting the opioid epidemic. Most recently, however, a complaint has been lodged against the United States, which has great potential to shape future litigation. Specifically, on... Read More
Blogs & Articles | Chain Pharmacies | Community, Retail Pharmacies | Federal and State Fraud and Abuse Counseling | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA

In a recent trend, the government is increasing investigations and prosecutions of pharmacies alleging health care fraud and False Claims Act (“FCA”) violations based on inventory shortages. Multiple governmental offices, including the... Read More
Blogs & Articles | Community, Retail Pharmacies | Federal and State Fraud and Abuse Counseling | Life Sciences | Pharmacy Law | White Collar Criminal Defense & Government Investigations

The Department of Justice (“DOJ” or the “Government”) and Bartell Drug, Inc. (“Bartell”), a Washington State pharmacy chain of approximately 70 pharmacies, recently reached a civil settlement in which Bartell agreed to pay a fine... Read More
Blogs & Articles | Chain Pharmacies | Community, Retail Pharmacies | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA | White Collar Criminal Defense & Government Investigations

As the opioid crisis continues to result in devastating consequences throughout the country, the U.S. Department of Justice (the “DOJ”) is broadening its opioid enforcement to all stakeholders involved in the opioid supply chain including,... Read More
Blogs & Articles | Community, Retail Pharmacies | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA

At a court hearing on November 24, 2020, a bankruptcy judge approved a settlement entered in late October between Purdue Pharma L.P. (“Purdue”) and the Department of Justice (“DOJ”), under which Purdue Pharma L.P. plead guilty in New Jersey... Read More
Pain Management Compliance | White Collar Defense and Government Investigation

On April 9th, 2019, U.S. Department of Health and Human Services Office of the Inspector General (HHS-OIG) and Department of Justice (DOJ) announced one of the largest health care fraud schemes involving several telemedicine companies, dozens of... Read More
Healthcare | Healthcare Law | Telehealth and Telemedicine

On September 9, 2020, the Justice Department (DOJ) announced a 77-year old and 65-year old were sentenced to 28-months and 24-months, respectively, for their part in a compounded medication scheme that cost the TRICARE program $65 million in actual... Read More
All types of single and multi-specialty medical practice groups | Blogs & Articles | Federal and State Fraud and Abuse Counseling | Healthcare

On September 9, 2020, the Justice Department (DOJ) announced an acute care hospital located in West Virginia (Hospital) agreed to pay the United States a total of Five-Hundred Million Dollars to resolve claims that it violated the Federal False... Read More
Blogs & Articles | Healthcare | Healthcare Practice Compliance | White Collar Criminal Defense & Government Investigations | White Collar Defense and Government Investigation